Cinanserin (INN) is a 5-HT2A and 5-HT2C receptor antagonist which was discovered in the 1960s.

[1] The molecule is an inhibitor of the 3C-like protease of SARS-CoV-1[2] and SARS-CoV-2.

[3] This drug article relating to the nervous system is a stub.

You can help Wikipedia by expanding it.